Carcinoma with apocrine differentiation is characterized in the fifth edition of the WHO Classification of Breast Tumors by apocrine morphology in greater than 90% of tumor cells combined with an ER negative, PR negative, AR positive immunophenotype. This evidence concerns the gene AR and neoplasm.